Table 1 Characteristics of the studied population and univariate comparisons (univariate logistic regression analyses) between age- and FEV 1 -matched (3:1 ratio) men (n = 275) and women (n = 107)
From: Impact of gender on COPD expression in a real-life cohort
Variable | Men | Women | P value |
|---|---|---|---|
Age* | 63 [57–71] | 63 [56–70] | 0.68 |
Pack-years | 41 [25–55] | 40 [30–55] | 0.65 |
BMI | 25 (22–29) | 24 (20–28) | 0.02 |
FEV1 (%)* | 46 [36–62] | 47 [37–65] | 0.71 |
Exacerbations/patient/year | 1 [0–2] | 1 [0–2] | 0.56 |
Dyspnea (MRC) | 1 [1,2] | 2 [1-3] | 0.0003 |
SGRQ total | 43 [30–59] | 46 [32–60] | 0.35 |
BOD index | 2 [1-4] | 3 [1-4] | <0.0001 |
Denutrition BMI ≤18.5 kg/m2 | 8% | 18% | 0.004 |
Obesity BMI > 30 kg/m2 | 21% | 15% | 0.18 |
Comorbid asthma | 13% | 10% | 0.42 |
Seasonal rhinitis | 9% | 16% | 0.04 |
Occupational exposure | 41% | 15% | <0.0001 |
Chronic bronchitis | 68% | 70% | 0.84 |
Hypertension | 35% | 33% | 0.71 |
Left heart failure | 10% | 15% | 0.12 |
Ischemic heart disease | 15% | 7% | 0.10 |
Peripheral artery disease | 13% | 10% | 0.58 |
Diabetes mellitus | 14% | 9% | 0.25 |
Sleep apnea syndrome | 8% | 2% | 0.04 |
Anxiety (HAD anxiety ≥10) | 29% | 41% | 0.02 |
Depression (HAD Depression ≥10) | 15% | 23% | 0.56 |